|
21.05.2018 21:31:50
|
DGAP-Adhoc: Evotec and Celgene enter into strategic oncology partnership
|
DGAP-Ad-hoc: EVOTEC AG / Key word(s): Alliance Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN: DE 000 566480 9, WKN 566480) announced today that Evotec and Celgene Corporation ("Celgene") have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology. Under the terms of the agreement, Evotec will receive an upfront payment of $ 65 m and may be eligible to receive significant milestone payments as well as tiered royalties on each licensed programme. Celgene receives exclusive opt-in rights to license worldwide rights to all programmes developed within this collaboration. Contact: Dr Werner Lanthaler, Chief Executive Officer, Evotec AG, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49.(0)40.560 81-242, werner.lanthaler@evotec.com
21-May-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Evotec AG |
| Manfred Eigen Campus / Essener Bogen 7 | |
| 22419 Hamburg | |
| Germany | |
| Phone: | +49 (0)40 560 81-0 |
| Fax: | +49 (0)40 560 81-222 |
| E-mail: | info@evotec.com |
| Internet: | www.evotec.com |
| ISIN: | DE0005664809 |
| WKN: | 566480 |
| Indices: | TecDAX |
| Listed: | Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| End of Announcement | DGAP News Service |
|
|
688027 21-May-2018 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu EVOTEC SEmehr Nachrichten
|
13.02.25 |
Börse Frankfurt in Grün: TecDAX legt am Donnerstagnachmittag zu (finanzen.at) | |
|
13.02.25 |
EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group) | |
|
13.02.25 |
Gewinne in Frankfurt: TecDAX fester (finanzen.at) | |
|
13.02.25 |
Freundlicher Handel in Frankfurt: TecDAX startet im Plus (finanzen.at) | |
|
12.02.25 |
EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group) | |
|
11.02.25 |
MDAX-Handel aktuell: MDAX sackt schlussendlich ab (finanzen.at) | |
|
11.02.25 |
TecDAX aktuell: TecDAX letztendlich mit Zuschlägen (finanzen.at) | |
|
11.02.25 |
TecDAX-Handel aktuell: TecDAX am Nachmittag fester (finanzen.at) |
Analysen zu EVOTEC SEmehr Analysen
| 03.02.25 | EVOTEC Buy | Warburg Research | |
| 12.12.24 | EVOTEC Buy | Warburg Research | |
| 25.11.24 | EVOTEC Sell | Deutsche Bank AG | |
| 22.11.24 | EVOTEC Outperform | RBC Capital Markets | |
| 18.11.24 | EVOTEC Sell | Deutsche Bank AG |
Aktien in diesem Artikel
| EVOTEC SE | 8,79 | 3,29% |
|
Letzte Top-Ranking Nachrichten
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.